Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Tivozanib by Kyowa Kirin for Diabetic Macular Edema: Likelihood of Approval
Tivozanib is under clinical development by Kyowa Kirin and currently in Phase II for Diabetic Macular Edema. According to GlobalData,...
Data Insights
Tivozanib by Kyowa Kirin for Wet (Neovascular / Exudative) Macular Degeneration: Likelihood of Approval
Tivozanib is under clinical development by Kyowa Kirin and currently in Phase II for Wet (Neovascular / Exudative) Macular Degeneration....